|
|
![]() |
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online 30 September 2008
doi: 10.1242/jcs.034660
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Research Article |
stabilization in inflammationThe Wolfson Institute for Biomedical Research, University College London, Gower Street, London WC1E 6BT, UK
* Author for correspondence (e-mail: s.moncada{at}ucl.ac.uk)
Accepted 8 July 2008
Activation of murine-derived J774.A1 macrophages with interferon
and lipopolysaccharide leads to a progressive mitochondrial defect characterized by inhibition of oxygen consumption and a decrease in the generation of ATP by oxidative phosphorylation. These changes are dependent on the generation of nitric oxide (NO) by an inducible NO synthase that becomes a significant consumer of oxygen. Furthermore, in these activated cells there is a biphasic stabilization of the hypoxia-inducible factor HIF1
, the second phase of which is also dependent on the presence of NO. The mitochondrial defect and stabilization of HIF1
synergize to activate glycolysis, which, at its maximum, generates quantities of ATP greater than those produced by non-activated cells. Nevertheless, the amount of ATP generated is not sufficient to fulfil the energy requirements of the activated cells, probably leading to a progressive energy deficit with the consequent inhibition of cell proliferation and death.
Key words: Nitric oxide, Mitochondria, HIF1
, Inflammation, Glycolysis, Oxidative phosphorylation
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?